• Accueil >
  • Publications >
  • High-content drug screening in zebrafish xenografts reveals high efficacy of dual MCL-1/BCL-XL inhibition against Ewing sarcoma

High-content drug screening in zebrafish xenografts reveals high efficacy of dual MCL-1/BCL-XL inhibition against Ewing sarcoma

1 févr. 2023Cancer Letters

DOI : 10.1016/j.canlet.2022.216028

Auteurs

Sarah Grissenberger, Caterina Sturtzel, Andrea Wenninger-Weinzierl, Branka Radic-Sarikas, Eva Scheuringer, Lisa Bierbaumer, Vesnie Etienne, Fariba Némati, Susana Pascoal, Marcus Tötzl, Eleni M. Tomazou, Martin Metzelder, Eva M. Putz, Didier Decaudin, Olivier Delattre, Didier Surdez, Heinrich Kovar, Florian Halbritter, Martin Distel